David Lichtshtein

659 total citations
8 papers, 567 citations indexed

About

David Lichtshtein is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Small Animals. According to data from OpenAlex, David Lichtshtein has authored 8 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 1 paper in Small Animals. Recurrent topics in David Lichtshtein's work include Neuroscience and Neuropharmacology Research (4 papers), Receptor Mechanisms and Signaling (4 papers) and Ion channel regulation and function (2 papers). David Lichtshtein is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Receptor Mechanisms and Signaling (4 papers) and Ion channel regulation and function (2 papers). David Lichtshtein collaborates with scholars based in United States and Israel. David Lichtshtein's co-authors include Arthur J. Blume, H. Ronald Kaback, Robert H. Belmaker, Ranan Rimón, Joseph Biederman, J. Dobkin and Richard P. Ebstein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The British Journal of Psychiatry and Life Sciences.

In The Last Decade

David Lichtshtein

8 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Lichtshtein United States 7 406 325 67 27 26 8 567
T P Kenakin United States 9 530 1.3× 408 1.3× 73 1.1× 20 0.7× 21 0.8× 11 662
Doreen Robinson United States 6 461 1.1× 299 0.9× 46 0.7× 16 0.6× 10 0.4× 6 561
Liane Reif‐Lehrer United States 17 424 1.0× 291 0.9× 94 1.4× 14 0.5× 14 0.5× 37 677
Geoffrey Grant United States 12 372 0.9× 222 0.7× 56 0.8× 15 0.6× 62 2.4× 23 1.0k
Helen Boyd Australia 12 240 0.6× 109 0.3× 65 1.0× 22 0.8× 42 1.6× 18 461
Isabelle Van Liefde Belgium 13 443 1.1× 219 0.7× 102 1.5× 37 1.4× 26 1.0× 24 671
Sara F. Kwong United States 7 266 0.7× 177 0.5× 61 0.9× 28 1.0× 19 0.7× 12 505
Pamlea J. Nelson United States 13 615 1.5× 448 1.4× 80 1.2× 53 2.0× 20 0.8× 15 981
M.G.P. Vale Portugal 12 355 0.9× 139 0.4× 40 0.6× 32 1.2× 13 0.5× 29 483
Jane H. Humm United States 9 222 0.5× 158 0.5× 60 0.9× 40 1.5× 17 0.7× 17 491

Countries citing papers authored by David Lichtshtein

Since Specialization
Citations

This map shows the geographic impact of David Lichtshtein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lichtshtein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lichtshtein more than expected).

Fields of papers citing papers by David Lichtshtein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Lichtshtein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lichtshtein. The network helps show where David Lichtshtein may publish in the future.

Co-authorship network of co-authors of David Lichtshtein

This figure shows the co-authorship network connecting the top 25 collaborators of David Lichtshtein. A scholar is included among the top collaborators of David Lichtshtein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Lichtshtein. David Lichtshtein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lichtshtein, David, et al.. (1980). Receptor-mediated inhibitions of NG108-15 adenylate cyclase: essential role of Na+ and GTP.. PubMed. 21. 339–48. 3 indexed citations
2.
Blume, Arthur J., et al.. (1979). Regulation of the Neuroblastoma X Glioma Hybrid Opiate Receptors by Na+ and Guanine Nucleotides. Advances in experimental medicine and biology. 116. 163–174. 14 indexed citations
3.
Lichtshtein, David, H. Ronald Kaback, & Arthur J. Blume. (1979). Use of a lipophilic cation for determination of membrane potential in neuroblastoma-glioma hybrid cell suspensions. Proceedings of the National Academy of Sciences. 76(2). 650–654. 203 indexed citations
4.
Lichtshtein, David, et al.. (1979). Muscarinic receptor regulation of NG108-15 adenylate cyclase: requirement for Na+ and GTP.. PubMed. 5(5). 367–75. 26 indexed citations
5.
Blume, Arthur J., et al.. (1979). Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP.. Proceedings of the National Academy of Sciences. 76(11). 5626–5630. 162 indexed citations
6.
Lichtshtein, David, et al.. (1979). A physiological requirement of Na+ for the regulation of cAMP levels in intact NG108-15 cells. Life Sciences. 25(11). 985–991. 25 indexed citations
7.
Lichtshtein, David, et al.. (1979). Mechanism of monensin-induced hyperpolarization of neuroblastoma-glioma hybrid NG108-15.. Proceedings of the National Academy of Sciences. 76(6). 2580–2584. 84 indexed citations
8.
Lichtshtein, David, J. Dobkin, Richard P. Ebstein, et al.. (1978). Gamma-Aminobutyric Acid (GABA) in the CSF of Schizophrenic Patients Before and After Neuroleptic Treatment. The British Journal of Psychiatry. 132(2). 145–148. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026